Achieve Life Sciences (ACHV) Short term Debt (2022 - 2026)

Achieve Life Sciences (ACHV) has 6 years of Short term Debt data on file, last reported at $1.6 million in Q4 2025.

• Quarterly Short term Debt changed N/A year-over-year to $1.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.6 million (changed N/A YoY) and the FY2025 annual result came in at $1.6 million, changed N/A from the prior year.
• Short term Debt grew to $1.6 million in Q4 2025, from $1.4 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $17.1 million in Q1 2024 to a low of $528000.0 in Q4 2023.
• A 4-year average of $7.1 million and a median of $1.6 million in 2025 frame the typical range for Short term Debt.
• Annual changes were most pronounced in 2023 — Short term Debt slumped 96.71% — and 2024, when it grew 4.7%.
• Tracing ACHV's Short term Debt over 4 years: stood at $16.1 million in 2022, then tumbled by 96.71% to $528000.0 in 2023, then surged by 1567.42% to $8.8 million in 2024, then slumped by 82.31% to $1.6 million in 2025.
• The last three Short term Debt figures came in at $1.6 million (Q4 2025), $1.4 million (Q3 2025), and $1.2 million (Q2 2025), per Business Quant data.